Follow Curanex Pharmaceuticals Inc. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
1 Story in coverage 0 Programs 0 Registered trials 8-K Oct 19 Latest SEC filing Oct 19 Latest story
Timeline 1 Pipeline 0 Trials 0
Details
Headquarters Jericho, NY Incorporated Nevada Industry Pharmaceutical Preparations Also known as CURX How the company describes itself Curanex Pharmaceuticals develops Phyto-N, a therapeutic in preclinical and IND-enabling stages for ulcerative colitis, with planned IND submission in Q4 2026. Based in Jericho, New York, the company evaluates additional pipeline opportunities. source
Sign in